1. Academic Validation
  2. Key Players of Hepatic Fibrosis

Key Players of Hepatic Fibrosis

  • J Interferon Cytokine Res. 2020 Oct;40(10):472-489. doi: 10.1089/jir.2020.0059.
Reham M Dawood 1 Mai A El-Meguid 1 Ghada Maher Salum 1 Mostafa K El Awady 1
Affiliations

Affiliation

  • 1 Genetic Engineering Division, Department of Microbial Biotechnology, National Research Centre, Giza, Egypt.
Abstract

Hepatic fibrosis is a complex mechanism defined by the net deposition of the extracellular matrix (ECM) owing to liver injury caused by multiple etiologies such as viral hepatitis and nonalcoholic fatty liver disease. Many cell types are implicated in liver fibrosis development and progression. In general, liver fibrosis starts with the recruitment of inflammatory immune cells to generate cytokines, growth factors, and other activator molecules. Such chemical mediators drive the hepatic stellate cells (HSCs) to activate the production of the ECM component. The activation of HSC is thus a crucial event in the fibrosis initiation, and a significant contributor to collagen deposition (specifically type I). This review explores the causes and mechanisms of hepatic fibrosis and focuses on the roles of key molecules involved in liver fibro genesis, some of which are potential targets for therapeutics to hamper liver fibro genesis.

Keywords

HBV; HCC; HCV; extracellular matrix (ECM); hepatic fibrosis; hepatic stellate cells (HSCs); liver.

Figures